Aminophylline for treatment of postdural puncture headache
A randomized clinical trial
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 28, 2017
- Accepted in final form January 25, 2018
- First Published March 23, 2018.
Article Versions
- Previous version (March 23, 2018 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Chuanjie Wu, MD,
- Dongsheng Guan, MD,
- Ming Ren, MD,
- Zhengfei Ma, MD,
- Changming Wan, MD,
- Yinglin Cui, MD,
- Ping Zhong, MD,
- Wenbo Zhao, MD,
- Chuanhui Li, MD,
- Feng Yan, MD,
- Jinqiu Xie, MD,
- Fang Xue, MD,
- Yajun Lian, MD,
- Hongbo Liu, MD,
- Cui Wang, MD,
- Xunming Ji, MD and
- Nanchang Xie, MD
- Chuanjie Wu, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Natural Science Foundation of China,81701287, Lead investigator,2015-2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Dongsheng Guan, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ming Ren, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Zhengfei Ma, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Changming Wan, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yinglin Cui, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ping Zhong, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Wenbo Zhao, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Chuanhui Li, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Feng Yan, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jinqiu Xie, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Fang Xue, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yajun Lian, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hongbo Liu, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cui Wang, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Natural Science Foundation of China,81701272, Lead investigator,2014-2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Xunming Ji, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nanchang Xie, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Natural Science Foundation of China, 81571260, Lead investigator,2016-2020
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (C. Wu, Y.L., H.L., C. Wang, N.X.), First Affiliated Hospital of Zhengzhou University; Department of Neurology (D.G., Y.C.), Second Affiliated Hospital of Henan University of Traditional Chinese Medicine; Department of Neurosurgery (M.R., W.Z., C.L., F.Y., X.J.), Xuanwu Hospital Capital Medical University, Beijing; Department of Neurology (Z.M., P.Z.), Suzhou Municipal Hospital, Anhui; Department of Neurology (C. Wan, J.X.), Jinzhou Central Hospital, Liaoning; and Department of Neurology (F.X.), Second Hospital of Hebei Medical University, Shijiazhuang, China.
- Correspondence
Dr. N. Xie xienanchanghn{at}163.com
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Alert Me
Recommended articles
-
Articles
Pregabalin for the treatment of postherpetic neuralgiaA randomized, placebo-controlled trialR.H. Dworkin, A.E. Corbin, J.P. Young, Jr. et al.Neurology, April 22, 2003 -
Article
Postdural puncture headache in migraineurs and nonheadache subjectsA prospective studyW.P.J. van Oosterhout, A.A. van der Plas, E.W. van Zwet et al.Neurology, February 06, 2013 -
Article
Effect of fremanezumab on quality of life and productivity in patients with chronic migraineRichard B. Lipton, Joshua M. Cohen, Sanjay K. Gandhi et al.Neurology, August 03, 2020 -
Articles
A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritisF. Sellebjerg, H. Schaldemose Nielsen, J.L. Frederiksen et al.Neurology, April 01, 1999